BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27854309)

  • 1. QSAR Study for Carcinogenic Potency of Aromatic Amines Based on GEP and MLPs.
    Song F; Zhang A; Liang H; Cui L; Li W; Si H; Duan Y; Zhai H
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27854309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model.
    Franke R; Gruska A; Giuliani A; Benigni R
    Carcinogenesis; 2001 Sep; 22(9):1561-71. PubMed ID: 11532881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based structure-activity relationship (SAR) analysis of aromatic amines and nitroaromatics carcinogenicity via statistical analyses based on CPDB.
    Wan WX; Chen Y; Zhang J; Shen F; Luo L; Deng SH; Xiao H; Zhou W; Deng OP; Yang H; Xiao YL; Huang CR; Tian D; He JS; Wang YJ
    Toxicol In Vitro; 2019 Aug; 58():13-25. PubMed ID: 30878698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative correlation of mutagenic and carcinogenic potencies for heterocyclic amines from cooked foods and additional aromatic amines.
    Hatch FT; Knize MG; Moore DH; Felton JS
    Mutat Res; 1992 Jun; 271(3):269-87. PubMed ID: 1378200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of nitrenium ion selectivities with quantitative mutagenicity and carcinogenicity of the corresponding amines.
    Novak M; Rajagopal S
    Chem Res Toxicol; 2002 Dec; 15(12):1495-503. PubMed ID: 12482231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSARs of aromatic amines: identification of potent carcinogens.
    Franke R; Gruska A; Bossa C; Benigni R
    Mutat Res; 2010 Sep; 691(1-2):27-40. PubMed ID: 20600167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural motifs modulating the carcinogenic risk of aromatic amines.
    Benigni R; Worth A; Netzeva T; Jeliazkova N; Bossa C; Gruska A; Franke R
    Environ Mol Mutagen; 2009 Mar; 50(2):152-61. PubMed ID: 19152383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable selection by an evolution algorithm using modified Cp based on MLR and PLS modeling: QSAR studies of carcinogenicity of aromatic amines.
    Shen Q; Jiang JH; Shen GL; Yu RQ
    Anal Bioanal Chem; 2003 Jan; 375(2):248-54. PubMed ID: 12560968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fisher discriminant analysis for carcinogenic potency of aromatic amines].
    Zhu Y; Yu Y; Chen X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Jan; 33(1):21-5. PubMed ID: 11864450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of mutagenicity of aromatic and heteroaromatic amines from structure: a hierarchical QSAR approach.
    Basak SC; Mills DR; Balaban AT; Gute BD
    J Chem Inf Comput Sci; 2001; 41(3):671-8. PubMed ID: 11410045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of QSARs and characterization of structural basis of bioactivity using partial order theory and formal concept analysis: a case study with mutagenicity.
    Restrepo G; Basak SC; Mills D
    Curr Comput Aided Drug Des; 2011 Jun; 7(2):109-21. PubMed ID: 21542792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning predictive classification models for the carcinogenic activity of activated metabolites derived from aromatic amines and nitroaromatics.
    Halabi A; Rincón E; Chamorro E
    Toxicol In Vitro; 2022 Jun; 81():105347. PubMed ID: 35318113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationship investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella Typhimurium TA100.
    Debnath AK; Lopez de Compadre RL; Shusterman AJ; Hansch C
    Environ Mol Mutagen; 1992; 19(1):53-70. PubMed ID: 1732104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoidance of the Ames test liability for aryl-amines via computation.
    McCarren P; Bebernitz GR; Gedeck P; Glowienke S; Grondine MS; Kirman LC; Klickstein J; Schuster HF; Whitehead L
    Bioorg Med Chem; 2011 May; 19(10):3173-82. PubMed ID: 21524589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity (QSAR) relationships of mutagenic aromatic and heterocyclic amines.
    Hatch FT; Colvin ME
    Mutat Res; 1997 May; 376(1-2):87-96. PubMed ID: 9202742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the genotoxicity of secondary and aromatic amines using data subsetting to generate a model ensemble.
    Mattioni BE; Kauffman GW; Jurs PC; Custer LL; Durham SK; Pearl GM
    J Chem Inf Comput Sci; 2003; 43(3):949-63. PubMed ID: 12767154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.